Acumen Pharmaceuticals, Inc. (ABOS)

Acumen Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	46.83	35.63	66.89	130.1	122.16	43.78
Short-Term Investments	79.78	135.93	176.64	47.5	72.08	-
Cash & Short-Term Investments	126.61	171.56	243.52	177.61	194.24	43.78
Cash Growth	-36.80%	-29.55%	37.11%	-8.56%	343.70%	568.15%
Accounts Receivable	-	-	-	-	-	0.11
Other Receivables	0.72	0.63	0.4	0.11	0.1	-
Receivables	0.72	0.63	0.4	0.11	0.1	0.11
Inventory	-	0.16	0.1	0.2	0.08	0.09
Prepaid Expenses	0.7	0.86	0.81	1.11	1.51	0.01
Other Current Assets	4.12	5.1	1.79	1.31	2.73	0.45
Total Current Assets	132.15	178.31	246.62	180.33	198.66	44.43
Property, Plant & Equipment	0.29	0.34	0.5	0.27	0.04	-
Long-Term Investments	9.44	59.97	62.55	15.84	31.62	-
Other Long-Term Assets	0.34	0.38	0.45	0.15	0.01	-
Total Assets	142.22	238.99	310.13	196.59	230.33	44.43
Accounts Payable	0.68	5.65	1.38	1.64	1.09	0.53
Accrued Expenses	17.18	21.6	10.51	5.94	3.86	0.33
Current Portion of Leases	0.15	0.13	0.87	0.11	-	-
Other Current Liabilities	0.35	0.23	0.21	0.13	0.2	5.5
Total Current Liabilities	21.96	27.61	12.97	7.81	5.15	6.37
Long-Term Debt	27.05	29.42	29.9	-	-	-
Long-Term Leases	0.04	0.15	0.28	-	-	-
Total Liabilities	49.05	57.18	43.15	7.81	5.15	6.37
Common Stock	0.01	0.01	0.01	0	0	-
Additional Paid-In Capital	514.38	506.99	489.45	359.95	352.98	8.37
Retained Earnings	-421.32	-325.13	-222.8	-170.43	-127.57	-26.97
Comprehensive Income & Other	0.11	-0.05	0.31	-0.75	-0.23	-
Total Common Equity	93.17	181.82	266.97	188.78	225.18	-18.59
Shareholders' Equity	93.17	181.82	266.97	188.78	225.18	38.06
Total Liabilities & Equity	142.22	238.99	310.13	196.59	230.33	44.43
Total Debt	30.84	29.7	31.05	0.11	-	-
Net Cash (Debt)	105.22	201.82	275.03	193.34	225.86	43.78
Net Cash Growth	-54.03%	-26.62%	42.25%	-14.40%	415.92%	568.15%
Net Cash Per Share	1.74	3.36	5.66	4.76	11.26	104.45
Filing Date Shares Outstanding	60.57	60.57	60.08	41.03	40.47	0.42
Total Common Shares Outstanding	60.57	60.09	57.91	41.03	40.47	0.42
Working Capital	110.2	150.7	233.64	172.52	193.51	38.06
Book Value Per Share	1.54	3.03	4.61	4.60	5.56	-44.35
Tangible Book Value	93.17	181.82	266.97	188.78	225.18	-18.59
Tangible Book Value Per Share	1.54	3.03	4.61	4.60	5.56	-44.35

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q